| Product Code: ETC9959685 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Asthma Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Asthma Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Asthma Treatment Market - Industry Life Cycle |
3.4 United States (US) Asthma Treatment Market - Porter's Five Forces |
3.5 United States (US) Asthma Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 United States (US) Asthma Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) Asthma Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Asthma Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of asthma in the US population |
4.2.2 Technological advancements in asthma treatment options |
4.2.3 Growing awareness about asthma management and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for asthma treatment products |
4.3.2 High cost associated with asthma medications and therapies |
4.3.3 Limited access to healthcare services for some segments of the population |
5 United States (US) Asthma Treatment Market Trends |
6 United States (US) Asthma Treatment Market, By Types |
6.1 United States (US) Asthma Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Asthma Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 United States (US) Asthma Treatment Market Revenues & Volume, By Long-term Asthma Control Medications, 2021- 2031F |
6.1.4 United States (US) Asthma Treatment Market Revenues & Volume, By Quick-relief (Rescue) Medications, 2021- 2031F |
6.2 United States (US) Asthma Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Asthma Treatment Market Revenues & Volume, By Inhaled, 2021- 2031F |
6.2.3 United States (US) Asthma Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.4 United States (US) Asthma Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 United States (US) Asthma Treatment Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3 United States (US) Asthma Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Asthma Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.3 United States (US) Asthma Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.4 United States (US) Asthma Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United States (US) Asthma Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Asthma Treatment Market Export to Major Countries |
7.2 United States (US) Asthma Treatment Market Imports from Major Countries |
8 United States (US) Asthma Treatment Market Key Performance Indicators |
8.1 Number of asthma diagnoses in the US |
8.2 Adoption rate of new asthma treatments and technologies |
8.3 Patient adherence to prescribed asthma treatment plans |
8.4 Rate of hospitalizations due to severe asthma attacks |
8.5 Percentage of healthcare providers offering comprehensive asthma management services |
9 United States (US) Asthma Treatment Market - Opportunity Assessment |
9.1 United States (US) Asthma Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 United States (US) Asthma Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) Asthma Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Asthma Treatment Market - Competitive Landscape |
10.1 United States (US) Asthma Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Asthma Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here